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Abstract 
Glutamate-134 (E134) is proposed to act as the general acid/base during the hydrolysis reaction catalyzed by 
the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) from Haemophilus influenzae. To 
date, no direct evidence has been reported for the role of E134 during catalytic turnover by DapE. In order to 
elucidate the catalytic role of E134, altered DapE enzymes were prepared in which E134 was substituted with an 
alanine and an aspartate residue. The Michaelis constant (K m) does not change upon substitution with aspartate 
but the rate of the reaction changes drastically in the following order: glutamate (100% activity), aspartate 
(0.09%), and alanine (0%). Examination of the pH dependence of the kinetic constants k cat and K m for E134D-
DapE revealed ionizations at pH 6.4, 7.4, and approximately 9.7. Isothermal titration calorimetry experiments 
revealed a significant weakening in metal K d values of E134D-DapE. D134 and A134 perturb the second divalent 
metal binding site significantly more than the first, but both altered enzymes can still bind two divalent metal 
ions. Structural perturbations of the dinuclear active site of DapE were also examined for two E134-substituted 
forms, namely E134D-DapE and E134A-DapE, by UV–vis and electron paramagnetic resonance (EPR) 
spectroscopy. UV–vis spectroscopy of Co(II)-substituted E134D-DapE and E134A-DapE did not reveal any 
significant changes in the electronic absorption spectra, suggesting that both Co(II) ions in E134D-DapE and 
E134A-DapE reside in distorted trigonal bipyramidal coordination geometries. EPR spectra of [Co_(E134D-DapE)] 
and [Co_(E1341A-DapE] are similar to those observed for [CoCo(DapE)] and somewhat similar to the spectrum 
of [Co(H2O)6]2+ which typically exhibit E/D values of approximately 0.1. Computer simulation returned an axial g-
tensor with g (x,y)=2.24 and E/D=0.07; g z was only poorly determined, but was estimated as 2.5–2.6. Upon the 
addition of a second Co(II) ion to [Co_(E134D-DapE)] and [Co_(E134A-DapE)], a broad axial signal was observed; 
however, no signals were observed with B 0||B 1 (“parallel mode”). On the basis of these data, E134 is 
intrinsically involved in the hydrolysis reaction catalyzed by DapE and likely plays the role of a general acid and 
base. 
Introduction 
According to recent estimates from the United States Centers for Disease Control and Prevention (the CDC), 
more than ten million people died worldwide from bacterial infections in 1995 [1]. Tuberculosis, for example, is 
the leading cause of death in adults by an infectious disease [2]. The importance of developing new drugs to 
fight infectious disease, such as tuberculosis, is underscored by the emergence of several pathogenic bacterial 
strains that are resistant to all currently available antibiotics [1, 3–5]. In order to overcome bacterial resistance 
to antibiotics, new enzyme targets must be located and small-molecule inhibitors developed. The meso-
diaminopimelate (mDAP)/lysine biosynthetic pathway offers several potential antibacterial targets that have yet 
to be explored [6–8]. Since both products of this pathway, mDAP and lysine, are essential components of the 
peptidoglycan cell wall in Gram-negative and some Gram-positive bacteria, inhibitors of enzymes within this 
pathway may provide a new class of antibiotics [4]. The fact that there are no similar pathways in mammals 
suggests that inhibitors of enzymes in the mDAP/lysine pathway will provide selective toxicity against bacteria 
and potentially have little or no effect on humans. 
One of the enzymes in this pathway [9], the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase 
(DapE), catalyzes the hydrolysis of N-succinyl-L,L-diaminopimelate (L,L-SDAP) to L,L-diaminopimelate and 
succinate [10]. It has been shown that deletion of the gene encoding DapE is lethal to Helicobacter 
pylori and Mycobacterium smegmatis [11, 12]. Even in the presence of lysine-supplemented media, the DapE 
deletion cell line of H. pylori was unable to grow; therefore, DapEs are essential for cell growth and proliferation. 
DapEs have been purified from Escherichia coli and Haemophilus influenzae, while the genes that encode for 
DapEs have been sequenced from several bacterial sources such as Corynebacterium glutamicum, H. pylori, 
and M. tuberculosis. The DapEs from E. coli and H. influenzae have been overexpressed in E. coli and purified to 
homogeneity [10, 13]. Both of these DapEs are small, dimeric enzymes (41.6 kDa per subunit) that require 2 
g atom of zinc per mole of polypeptide for full enzymatic activity [7, 10]. Sequence alignment of the DapE 
from H. influenzae with the aminopeptidase from Aeromonas proteolytica (AAP) and the structurally related 
carboxypeptidase G2 from Pseudomonas sp. strain RS-16 (CPG2) indicated that all of the amino acids that 
function as metal ligands in AAP and CPG2 are strictly conserved in DapE [10]. However, it should be noted that 
no catalytically important amino acid residues have been identified for DapE to date. 
Comparison of all known crystallographically characterized metallohydrolases, including AAP and CPG2, reveals 
some common features for both mononuclear and dinuclear hydrolases [14–17]. All have at least one bound 
water molecule and many contain an active-site carboxylate residue that does not function as a metal ligand. 
This carboxylate residue, usually a glutamate, often forms a hydrogen bond to a water molecule that is also 
bound to an active-site metal ion. The X-ray crystal structure of AAP reveals that an oxygen atom of glutamate-
151 (E151) forms a hydrogen bond with a water molecule that bridges between the two Zn(II) ions [18]. E151 
was recently shown to act as the proton shuttle during catalytic turnover [19]. On the basis of sequence 
alignment between DapE and AAP, glutamate-134 (E134) was proposed to function in an identical manner in 
DapE enzymes as E151 in AAP [10]. In order to gain an understanding of the catalytic role of E134 in the 
hydrolysis of N-succinyl-L,L-diaminopimelic acid, we prepared the E134A- and E134D-altered DapE enzymes and 
characterized each by kinetic and spectroscopic methods. These data indicate that E134 is intimately involved in 
catalysis and likely functions as the general acid/base. 
Materials and methods 
Reagents 
D,L-α,ε-DAP (98% pure), succinic anhydride, and ion-exchange resin (Dowex 50WX8–200, H+ form) were 
purchased from Sigma. Technically pure 2-naphthalenesulfonic acid (70%) was purchased from Aldrich, 
crystallized from a 5% aqueous solution of HCl, and dried in a vacuum desiccator over CaCl2 to give a white solid 
of 2-naphthalenesulfonic acid 1-hydrate, melting point 397–398 K (confirmed by NMR). Microcrystalline 
cellulose was purchased from EM Science. All solvents and additional chemicals were purchased from either 
Sigma or Fisher Scientific. 
Protein expression and purification 
The recombinant DapE from H. influenzae was expressed and purified, as previously described with minor 
modifications, from a stock culture kindly provided by John Blanchard [10]. Briefly, approximately 12 g of cell 
paste was suspended in 50 mL of 10 mM N-tris(hydroxymethyl)methylglycine (Tricine) buffer, pH 7.8, containing 
four protease inhibitor tablets (complete protease inhibitor tables, Boehringer Mannheim). Lysozyme (10 mg) 
was added to the mixture and stirred for 30 min at 277 K. Cells were lysed by sonication (Heat Systems-
Ultrasonics) at 1-min intervals, four repetitions, and the cell debris was removed by centrifugation for 40 min at 
12,000g. DNase (2 mg) was added and after approximately 20 min of incubation, the solution was loaded onto a 
fast-flow Q-sepharose anion-exchange column that had been pre-equilibrated with 10 mM Tricine buffer, pH 
7.8. A flow rate of 3 mL min−1 was used and a 600-min linear gradient of NaCl (0.2–0.5 M) was used to elute 
DapE. DapE activity was detected between 0.25 and 0.3 M NaCl. The active fractions were concentrated using an 
Amicon YM-10 membrane. Purified DapE from H. influenzae exhibited a single band on sodium dodecyl sulfate–
polyacrylamide gel electrophoresis, indicating M r=41,500. Protein concentrations were determined from the 
absorbance at 280 nm using a molar absorptivity calculated using the method developed by Gill and Hippel [20] 
(ε 280=36,040 M−1 cm−1). The protein concentration determined using this molar absorptivity was in close 
agreement to that obtained using a Bradford assay. Individual aliquots of purified DapE were stored in liquid 
nitrogen until needed. 
Site-directed mutagenesis 
Site-directed mutants were obtained using the Quick Change Site-Directed Mutagenesis Kit (Stratagene, La Jolla, 
CA, USA) following the procedure outlined by Stratagene. The following primers were used: 5′-GCA TTA TTG ATT 
ACC TCT GAT XXX GAG GCT ACC GC-3′ and 5′-GC GGT AGC CTC YYY ATC AGA GGT AAT CAA TAA TGC-3′ with GCT 
and GAC for XXX and AGC and GTC for YYY to prepare E134A- and E134D-altered DapE enzymes, respectively. 
Reaction products were transformed into E. coli XL1-Blue competent cells, grown on Luria–Bertani agarose 
plates containing ampicillin (100 μg mL−1). A single colony of each mutant was grown in 100 mL Luria–Bertani 
medium containing 100 μg mL−1 ampicillin. Plasmids were isolated using the QIAprep-Spin Miniprep Kit (QIAGEN, 
Valencia, CA, USA). Each mutation was confirmed by DNA sequencing (USU Center for Integrated BioSystems). 
Plasmids containing the altered DapE genes were transformed into E. coli BL21 Star (DE3) cells (Invitrogen, 
Carlsbad, CA, USA). 
Metal content measurements 
Apo-DapE was prepared by extensive dialysis for 3–4 days against 10 mM EDTA in 50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer, pH 7.5. DapE was then exhaustively dialyzed against metal-free 
(chelexed) 50 mM HEPES buffer, pH 7.5. Any remaining metal ions were estimated by comparing the activity of 
the apo-enzyme with a sample that had been reconstituted with Zn(II). DapE incubated with EDTA typically had 
less than 5% residual activity after dialysis. Apo-DapE samples were incubated with ZnCl2 (99.999%; Strem 
Chemicals, Newburyport, MA, USA) for 30 min prior to exhaustive dialysis into Chelex-treated buffer as 
previously reported [21]. 
Synthesis of N-succinyl-diaminopimelic acid 
The D,D and L,L isoforms of DAP were separated from the D,L isoform using the method described by Bergmann 
and Stein [22]. N-succinyl-diaminopimelic acid (SDAP) was synthesized using the procedure described by Lin et 
al. [23], providing an overall yield of 41% (1.84 g; 5.7 mmol) [24]. NMR (270 MHz, D2O, δ, ppm): 1.25–1.45 (m, 
2H), 1.55–1.90 (m, 4H), 2.29–2.52 (m, 4H), 3.64 (dd, 1H), 4.05 (dd, 1H), 4.76 (bs, H2O + ammonium ion). The L,L-
SDAP and N-succinyl-D,D-diaminopimelate (D,D-SDAP) isoforms were separated using an high-performance 
liquid chromatograph (Shimadzu SCL-10A VP) with a Chirobiotic T column (250 mm × 10 mm; Alltec). The 
isocratic mixture of 20% methanol in water (adjusted to pH 4) was used as the eluting solvent. The two isoforms 
were present in an approximate 1:1 ratio. 
Enzymatic assay of DapE 
The specific activity of E134A-DapE and E134D-DapE was determined by monitoring amide bond cleavage of L,L-
SDAP at 215 nm in 50 mM HEPES buffer, pH 7.5, in the presence of 3 equiv Zn(II). The kinetic 
parameters V max (velocity) and K m (Michaelis constant) were determined at pH 7.5 by quantifying the amide 
bond cleavage (decrease in absorbance) of L,L-SDAP at 225 nm (ε=698 M−1 cm−1) in triplicate. Enzyme activities 
are expressed as units per milligram, where one unit is defined as the amount of enzyme that releases 1 μmol 
of L,L-SDAP at 303 K in 1 min. Catalytic activities were determined with an error of ±10%. Initial rates were fit 
directly to the Michaelis–Menten equation to obtain the catalytic constants K m and k cat. 
Kinetic characterization of DapE with various divalent transition metal ions [Mn(II), Mg(II), Co(II), Ni(II), Cu(II), 
Zn(II), Cd(II)] in the active site was performed by placing apo-DapE in the presence of 100 μM ultrapure metal 
(99.999%; Strem Chemicals). After 1-h incubation period, the activity of metal-substituted DapE was determined 
by monitoring the hydrolysis of the substrate mixture D,D-, L,L-SDAP. 
Isothermal titration calorimetry 
Isothermal titration calorimetry measurements were carried out using a MicroCal OMEGA ultrasensitive titration 
calorimeter at 298±0.2 K. Association constants (K b) were obtained by fitting these data, after subtraction of the 
background heat of dilution, via an interactive process using the Origin software package. This software package 
uses a nonlinear least-squares algorithm which allows the concentrations of the titrant and the sample to be fit 
to the heat flow per injection by an equilibrium binding equation for two noninteracting sites. The K b value, 
enzyme–metal stoichiometry (n), and the change in enthalpy (ΔH 0) were allowed to vary during the fitting 
process. The divalent metal ion titrants and apo-enzyme solutions were prepared in chelexed HEPES buffer at pH 
7.5. Stock buffer solutions were thoroughly degassed before each titration. The enzyme solution (60–90 μM) 
was placed in the calorimeter cell and stirred at 200 rpm to ensure rapid mixing. Typically, 4–6 μL of titrant was 
delivered over 7.6 s with a 6-min interval between injections to allow for complete equilibration. Each titration 
was continued until 4.5–6 equiv M(II) had been added to ensure that no additional complexes were formed in 
excess titrant. A background titration, consisting of the identical titrant solution but only the buffer solution in 
the sample cell, was subtracted from each experimental titration to account for heat of dilution. The heat of 
reaction measured during the experiment was converted into association constants (K a) using the Gibbs free-
energy relationship: 
Δ𝐺0 = −𝑅𝑇ln⁡(𝐾a) = Δ𝐻
0 − 𝑇Δ𝑆0, 
(1) 
where R=1.9872 cal mol−1 K−1. The relationship between K a and K d is defined as 
𝐾d = 1/𝐾a. 
(2) 
pH profiles 
The enzymatic activities of DapE and the E134D form of DapE at pH values between 6.0 and 9.0 were measured 
using L,L-SDAP as the substrate. The conditions and methods used were identical to those described by Javid-
Majd and Blanchard [25]. Briefly, the concentration of each buffer used was 50 mM and the following buffers 
were used: phosphate (pH 6.0–8.0) and tris(hydroxymethyl)aminomethane (Tris) (pH 8.0–9.0). No additional 
Zn(II) was included in any of the buffers listed above pH 8.0; however, between pH 6.0 and 8.0, 0.1 mM Zn(II) 
was included in all the buffers. The kinetic parameters k cat, K m, and k cat/K m were determined using five to seven 
different substrate concentrations ranging from 0.67 to 3.0 times the observed K m value at each pH studied. 
Overlapping points for each buffer used were collected and the resulting data matched within ±5%. Kinetic 
parameters and fits to the kinetic curves were obtained using Igor Pro (Wavemetrix, Lake Oswego, OR, USA) by 
fitting the experimental data to the appropriate equations. 
Spectroscopic measurements 
Electronic absorption spectra were recorded with a Shimadzu UV-3101PC spectrophotometer with protein 
concentrations of approximately 1 mM. All apo-DapE variant samples used in the spectroscopic measurements 
were made rigorously anaerobic prior to a 30-min incubation period with Co(II) (CoCl2 purity 99.999% or greater; 
Strem Chemicals) at 273–298 K. All Co(II)-containing samples were handled throughout in an anaerobic glove 
box (Ar/5% H2, 1 ppm or less O2; Coy Laboratories). Electronic absorption spectra were normalized for the 
protein concentration and the absorption due to uncomplexed Co(II) (ε 512 nm=6.0 M−1 cm−1). Low-temperature 
electron paramagnetic resonance (EPR) spectroscopy was performed using a Bruker ESP-300E spectrometer 
equipped with an ER 4116 DM dual mode X-band cavity and an Oxford Instruments ESR-900 helium-flow 
cryostat. Enzyme concentrations for EPR were approximately 1 mM. Background spectra recorded with a buffer 
sample were aligned with and subtracted from experimental spectra as in earlier work [26]. EPR spectra were 
recorded at microwave frequencies of approximately 9.65 GHz: precise microwave frequencies were recorded 
for individual spectra to ensure precise g-alignment. All spectra were recorded at 100-kHz modulation 
frequency. Other EPR running parameters are specified in the figure legends for individual samples. Each variant 
was incubated with the appropriate amount of Co(II) for 30 min at 298 K and then frozen in an EPR tube for 
analysis. 
Results 
Kinetic studies on altered DapE enzymes 
The K m and k cat values for E134D-DapE were obtained by fitting the observed data to the Michaelis–Menten 
equation (Table 1). The k cat value obtained for E134D-DapE was approximately 1,000 times lower than that for 
wild-type (WT) DapE (50 mM phosphate buffer, pH 7.6); however, the observed K m value for E134D-DapE did 
not change significantly upon the substitution of the glutamate with aspartate. When E134 is replaced with a 
residue that cannot transfer a proton (E134A), no activity is observed. 
Table 1 Kinetic data for wild-type (WT) dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) 
and the glutamate-134 (E134) altered enzymes recorded at pH 7.5 
  kcat (s−1) Km (mM) Specific activity (U mg−1) 
WT DapE 140±10 0.73±0.05 180 
E134D-DapE 0.13±0.01 0.65±0.05 0.17 
E134A-DapE ND – – 
 
Activation of E134D-DapE by first-row transition metals 
Activation of apo-E134D-DapE by several first-row divalent transition metals was examined [24]. Substrate 
hydrolysis (k cat) of a 1.5 mM D,D-, L,L-SDAP buffered solution was monitored as a function of divalent metal ion 
concentration under anaerobic conditions (Fig. 1). Co(II) provides the most active E134D-DapE enzyme and is 
approximately 2 times more active than the Zn(II)-loaded form of DapE [10]. Interestingly, Mn(II) ions activate 
DapE but only approximately 20% of the Zn(II)-loaded DapE activity is observed. The relative ordering of the 
observed k cat values for D,D-, L,L-SDAP hydrolysis is Co(II)>Zn(II)>Cd(II)>Mn(II). The activity of E134D-DapE was 
also tested with Ni(II), Cu(II), and Mg(II) ions present but no substrate hydrolysis was observed under the 
experimental conditions used. 
 
Fig. 1 Activity of a 6 μM sample of E134D–dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase 
(DAPE) in the presence of various divalent transition metal ions determined in 50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer at pH 7.5. See “Site-directed mutagenesis” for an explanation of 
E134D 
 
Isothermal titration calorimetry 
The best fits obtained for the E134D-DapE and E134A-DapE altered enzymes provided n values of two for two 
noninteracting sites (Table 2). For WT DapE, Zn(II) and Co(II) bind tightly to the first metal binding site with 
dissociation constants (K d) of 0.44±0.05 and 0.14±0.05 μM, respectively (S.I. Swierczek, S. Mitra, K. Baron, and 
R.C. Holz, unpublished results). On the other hand, the observed K d values for Zn(II) binding to the first metal 
binding site of E134A-DapE and E134D-DapE are 0.62±0.05 and 1.3±0.5 μM, respectively (Fig. 2). For Co(II) 
binding to the first divalent metal binding sites of E134D-DapE and E134A-DapE, the observed K d values are 
0.028±0.005 and 0.094±0.005 μM, respectively (Fig. 3). On the other hand, the second metal binding site for WT 
DapE is significantly weaker for both Zn(II) (K d=1.4±0.5 μM) and Co(II) (K d=2.5±0.5 μM). For E134A-DapE and 
E134D-DapE, Zn(II) binding to the second metal binding sites exhibits K d values of 65.4 and 9.1 μM, respectively. 
Similarly, for Co(II) binding to the second metal binding sites of E134A-DapE and E134D-DapE, the 
observed K d values are 60.2±0.5 and 1.2±0.5 μM, respectively. 
Table 2 Isothermal titration calorimetry data for the Zn(II)-loaded and Co(II)-loaded WT, E134A-DapE and E134D-DapE altered enzymes 
  n Ka1, Ka2 (M−1) Ka1, Ka2 (μM) ΔH 01, ΔH 02 (kcal mol−1) TΔS01, TΔS02 (kcal mol−1) ΔG 01, ΔG 02 (kcal mol−1) 
[ZnZn(DapE)] 1.0 2.27×105 0.44 6.5 46 −7.3  
1.0 7.35×104 1.4 −3.4 10 −6.6 
[CoCo(DapE)] 1.0 7.14×105 0.14 −3.4 18 −9.0  
1.0 4.00×104 2.5 6.5 48 −8.0 
[ZnZn(E134D)] 1.0 7.88×104 1.3 0.30 7.0 −6.7  
1.1 1.10×104 9.1 21 26 −5.5 
[CoCo(E134D)] 0.9 3.52×106 0.028 5.3 14 −8.9  
1.0 8.08×104 1.24 7.3 14 −6.7 
[ZnZn(E134A)] 1.1 1.61×105 0.62 −0.21 6.9 −7.1  
1.1 1.56×103 65.4 61 66 −4.4 
[CoCo(E134A)] 0.8 1.06×106 0.094 9.0 17 −8.2  
1.0 1.61×103 60.2 3.2 7.6 −4.4 
See “Site-directed mutagenesis” for an explanation of E134A and E134D 
 
 
Fig. 2 Isothermal titration data for Zn(II) binding to the a E134D-DapE and b E134A-DapE enzymes in 50 mM 
HEPES buffer at pH 7.5. See “Site-directed mutagenesis” for an explanation of E134A 
 
 
Fig. 3 Isothermal titration data for Co(II) binding to the a E134D-DapE and b E134A-DapE enzymes in 50 mM 
HEPES buffer at pH 7.5 
 
pH dependence 
The pH dependence of the kinetic parameters of E134D-DapE was investigated over the pH range 6.0–9.0. The 
E134D-DapE altered enzyme displayed optimum catalytic efficiency at pH values between 7.5 and 8.5 (Fig. 4). 
Activity below pH 6.0 was not observed and K m values obtained above pH 9.0 were too large to measure with 
the current assay [10]. Phosphate (6.0–8.0) and Tris (8.5–9.0) buffers were used owing to their low absorbance 
at 215 nm. These kinetic data were plotted as log(parameter) versus pH and fit to Eq. 3: 
parameter = 𝑐/(1 + [H+]/𝐾1 + 𝐾2/[H
+]), 
(3) 
where parameter is k cat or k cat/K m and K 1 and K 2 are the respective ionization constants, while [H+] is the 
hydrogen ion concentration. The pH dependence of logK m (Fig. 4, top curve) was obtained by subtracting plots 
of log(k cat/K m) from log(k cat); thus, the inflection points reflect groups with ionizations at 6.4, 7.4, and 
approximately 9.7. The observed changes in k cat are small over the pH range 7.0–9.0, but a sharp drop is 
observed below pH 7.0, with a single inflection at 6.4 (Fig. 4, middle curve). Plots of log(K m) and log(k cat/K m) 
versus pH for E134D-DapE likely form bell-shaped curves but this assertion cannot be made conclusively owing 
to the lack of our ability to obtain data points above pH 9.0. Therefore, a plot of log(k cat/K m) versus pH reveals 
one inflection in the acidic range, at 7.3. An inflection in the basic range was estimated to be approximately 9.7 
(Fig. 4, bottom curve). 
 
Fig. 4 pH dependence of the observed kinetic parameters for the hydrolysis of N-succinyl-L,L-diaminopimelate 
(L , L -SDAP)by Zn(II)-loaded E134D-DapE. Top pH dependence of K m—obtained by subtraction of log(k cat/K m) 
from logk cat (solid line); pK e1=6.4, pK HS=7.4, pK e2=9.7. Middle pH dependence of logk cat—fit to the experimental 
data using Eq. 3 (solid line); pK ES1=6.4, pK ES2=9.7. Bottom pH dependence of log(k cat/K m)—fit to the 
experimental data using Eq. 3 (solid line); pK HS=7.4, pK e2=9.7. Fits were obtained using Igor Pro (Wavemetrix). 
Error bars are smaller than the symbols used 
 
Spectroscopic studies 
Electronic absorption spectra of the E134A- and E134D-altered DapE enzymes were recorded in the presence of 
1 and 2 equiv Co(II) ([Co_(E134A-DapE)], [CoCo(E134A-DapE)], [Co_(E134D-DapE)], and [CoCo(E134D-DapE)]). 
The addition of 1 equiv Co(II) to E134A-DapE provided a visible absorption spectrum with a maximum at 555 nm 
(ε 555=165 M−1 cm−1) (Fig. 5). Addition of a second equivalent of Co(II) to E134A-DapE resulted in an increase in 
absorbance at 555 nm to 174 M−1 cm−1, similar to the situation for WT DapE. Addition of 1 equiv Co(II) to E134D-
DapE produced a visible absorption spectrum with a maximum at 556 nm (ε 556=187 M−1 cm−1) (Fig. 5). Addition 
of a second equivalent of Co(II) to E134D-DapE increased the absorption intensity at 556 nm to 216 M−1 cm−1. 
 
Fig. 5 Electronic absorption spectra of Co(II)-loaded E134A-DapE and E134D-DapE recorded after the addition of 
one equivalent of Co(II) in 50 mM HEPES buffer at pH 7.5 
 
EPR spectra of [Co_(E134A-DapE)], [CoCo(E134A-DapE)], [Co_(E134D-DapE)], and [CoCo(E134D-DapE)] were 
recorded at several temperatures (3.5–70 K) and microwave powers (0.5–50 mW). EPR spectra of [Co_(E134D-
DapE)], [Co_(DapE)], and [CoCo(DapE)] are presented in Fig. 6. Upon addition of 0.25–1.0 equiv Co(II) to apo-
E134D-DapE or apo-E134A-DapE the spectra are similar to those observed for [CoCo(DapE)], AAP, the methionyl 
aminopeptidase from E. coli (EcMetAP-I), and somewhat similar to [Co(H2O)6]2+ which typically exhibit E/D values 
of approximately 0.1 [24, 26–28]. Computer simulation returned an axial g-tensor with g (x.y)=2.24 
and E/D=0.07; g z was only poorly determined, but was estimated as 2.5–2.6. Upon the addition of a second 
Co(II) to [Co_(E134D-DapE)] and [Co_(E134A-DapE)], a broad axial signal was observed. Since the axial zero-field 
splitting is unknown and g z is ill defined, calculation of the transition probability is not possible and thus 
accurate spin quantitation of the EPR-active Co(II) species is impossible. However, by direct comparison (peak 
height) with spectra from hexaaquo-Co(II), the spin concentrations of the spectra from [CoCo(E134A-DapE)] and 
[CoCo(E134D-DapE)] suggest approximately 2 mol of EPR-detectable Co(II) per mole of E134D-DapE and E134A-
DapE. No signals were observed with B 0||B 1 (“parallel mode”). 
 
Fig. 6 Comparison of the electron paramagnetic resonance (EPR) spectra of Co(II)-loaded E134D-DapE recorded 
after the addition of 1 equiv Co(II) with [Co_(DapE)] and [CoCo(DapE)]. The dashed line indicates the simulation 
of the [Co_(E134D-DapE)] EPR spectrum with g (x.y)=2.24 and E/D=0.07; g z was only poorly determined, but was 
estimated as 2.5–2.6. All EPR spectra were recorded at 10 K using a microwave power of 0.2 mW in 50 mM 
HEPES buffer at pH 7.5 
 
Discussion 
Metalloproteases containing dinuclear active sites, such as DapE [29], are promising targets for drug discovery. 
DapE is a particularly attractive target for the development of a new class of antibiotics owing to its role in cell 
wall synthesis in bacteria; however, very little is known about how DapE catalyzes the hydrolysis of L,L-SDAP 
to L,L-diaminopimelate and succinate. Alignment of several gene sequences of DapE enzymes with CPG2 and 
AAP [10] indicated that all of the amino acids that function as metal ligands are strictly conserved, including a 
proposed nonligating amino acid E134. On the basis of these alignment data [10] and X-ray crystallographic data 
reported for AAP and CPG2 [18, 30, 31], E134 corresponds to E151 in AAP. This amino acid residue was recently 
shown to function as both a general acid and a general base during catalysis [19]. E151 assists in deprotonating 
the metal-bound water molecule to a more nucleophilic hydroxo moiety, similar to that of glutamate-270 in 
carboxypeptidase A [32] and provides a proton to the newly formed N terminus of the outgoing peptide 
substrate. In order to determine the role of E134 in catalysis, we prepared the DapE-altered enzymes where 
E134 was changed to an aspartate or an alanine residue. 
The specific activity of E134D-DapE was determined in the presence of L,L-SDAP, which is the natural substrate 
for this enzyme. Kinetic parameters for Zn(II)-loaded WT and E134D, DapE indicate that, in general, the effect on 
activity is due to a decrease in k cat (Table 1) similar to that observed for AAP [19]. Interestingly, replacement of 
E134 with a residue that is still capable of transferring a proton or forming hydrogen bonds, such as aspartate, 
provided a DapE enzyme that remains active but exhibits only 0.09% of the observed WT DapE activity. 
The K m value does not significantly change, suggesting that substrate interacts normally with the active site. 
Similar to WT DapE, E134D-DapE can be activated by several divalent first-row transition metal ions, including 
Co(II), Cd(II), and Mn(II) [24]. Replacement of E134 with an alanine residue results in a totally inactive enzyme. 
These data indicate that E134 is absolutely required for catalytic turnover even though it has been proposed not 
to function as a Zn(II) ligand. 
The isothermal titration calorimetry measurements for Zn(II) binding to E134A-DapE and E134D-DapE 
provided K d values of 0.62 and 1.3 μM for the first metal binding sites, respectively. These values are 
approximately 1.4 and approximately 2.9 times weaker than the observed K d value for WT DapE. Interestingly, 
the first Co(II) binding event for E134A-DapE and E134D-DapE provided K d values of 0.094 and 0.028 μM, which 
are approximately 5 and approximately 15.0 times stronger than the WT binding of Co(II). In the absence of X-
ray crystallographic data, the observed changes in the K d values for Co(II) versus Zn(II) are difficult to explain; 
however, they are likely the result of the preference of Co(II) for five- or six-coordinate geometries versus four- 
or five-coordinate for Zn(II). For the second metal binding events, Zn(II) binds to E134A-DapE and E134D-DapE 
with K d values of 65.4 and 9.1 μM, respectively, while Co(II) binds to the second metal binding site 
with K d values of 60.2 and 1.24 μM, respectively. Therefore, E134D and E134A perturb the second divalent 
metal binding site significantly more than the first, but both altered enzymes can still bind two divalent metal 
ions. The Gibbs free energy does not change significantly upon substitution of E134 by aspartate or alanine and 
is similar to that observed for WT DapE [19]. Interestingly, the entropic factor (TΔS 0) drops sixfold for both 
E134A-DapE and E134D-DapE for the first metal binding event, which is consistent with the large change in K d. 
On the other hand, TΔS 0 increases significantly for the second Zn(II) binding event in the order 
E134A<E134D<WT DapE, suggesting a decrease in order around the second metal binding site. 
Ionizations derived from plots of log(k cat/K m) versus pH correspond to ionizations of the free enzyme and free 
substrate [33, 34]. On the basis of the available kinetic data for WT DapE [10] and the kinetic and X-ray 
crystallographic data for AAP [19, 33, 35], a simple, two-site model was used to describe the observed changes 
in ionization states of active-site residues with changing pH (Scheme 1). K m and k cat values were previously 
reported for Zn(II)-bound WT DapE over the pH range 6–9 and a plot of log(k cat/K m) versus pH provided a bell-
shaped curve with two inflections at pH 6.6 and 8.3 [10]. For E134D-DapE, plots of log(k cat/K m) versus pH likely 
form bell-shaped curves but this assertion cannot be made conclusively owing to our inability to obtain data 
points above pH 9.0. Fits of log(k cat/K m) for E134D-DapE provided a K E1 value of 6.4, while K E2 was estimated to 
be approximately 9.7. The K E1 value obtained for E134D-DapE matches well with that reported for WT DapE 
(K E1=6.6), consistent with its assignment as the ionization of a metal-centered water molecule. Interestingly, the 
observed K E2 value has shifted to a more basic pH value by approximately 1 pH unit. While the K E2 value 
reported here is simply an estimate, qualitatively, the log(k cat/K m) versus pH profile for E134D-DapE is clearly 
shifted to more basic pH values compared with that for WT DapE. The basic K E2 value suggests that an enzyme 
residue needs to be protonated for the substrate to bind. The presence of an ionizing group between pH 8.5 and 
9.5 for WT DapE and E134D-DapE, respectively, suggests a basic enzyme-centered residue must be protonated. 
Given the number of carboxylic acid residues on L,L-SDAP the most likely candidate would be an active-site 
lysine residue involved in substrate binding. 
 
Scheme 1 Equilibrium scheme for substrate binding to different protein protonation states of dapE 
 
For WT DapE, no change in k cat was observed in the pH range 7.0–9, but a sharp drop in k cat was observed 
below pH values of 7.0, which is identical to that observed for E134D-DapE. For WT DapE, a pK a value of 6.6 was 
extracted from fits of the data, which matches well with the pK a value of 6.4 observed for E134D-DapE. These 
data indicate that one ionizable group (pK ES) must be deprotonated in the enzyme–substrate complex for 
catalysis to occur (Scheme 1), and that a similar process is responsible for the observed changes in k cat for both 
the WT and the E134D-DapE enzymes. This pK a value likely corresponds to the ionization of a metal-centered 
water molecule, as previously suggested [10]. A second alternative would be the ionization of a carboxylic acid in 
the enzyme–substrate complex, similar to AAP [19, 34]; however, a change in the rate-limiting step of the 
reaction cannot be entirely ruled out. If the observed pK ES value at 6.4 is the ionization of a carboxylate residue 
(E134) that is required to be in an unprotonated form for the catalytic reaction to occur, one would expect to 
see a shift in this pK a versus that of the WT enzyme. Since this shift is not observed, this pK a value is likely the 
deprotonation of a metal-centered water molecule to a hydroxide as previously suggested [10]. 
Inspection of a plot of log(K m) versus pH for E134D-DapE provided a K HS value of 7.4. The observed inflection at 
pH 7.4 indicates that one group on the substrate or enzyme must be in the deprotonated form, resulting in 
increased substrate binding affinity, assisting enzyme–substrate complex formation. Assignment of these 
pK a values is difficult but the pK a value observed at pH 7.4 is likely due to one of the amino groups of L,L-SDAP 
since N-terminal amines typically exhibit pK as in the range 7.5–10.0. As previously suggested, K E2 is either a 
substrate-centered amino group or an enzyme-centered lysine residue [35]. Alternatively, the large number of 
negatively charged residues residing in the active site may raise the pK a of E134, suggesting that the observed 
pK a at 7.4 is that of E134D; however, given the similarity of this pK a with that of the substrate’s amino groups, 
this assignment is unlikely. 
To further examine the metal binding properties of E134A-DapE and E134D-DapE, electronic absorption spectra 
of the Co(II)-loaded forms of each altered enzyme were recorded. Upon the addition of 1 equiv Co(II) under 
anaerobic conditions, three resolvable d–d transitions in the 500–600-nm range (at λ max ε=165–190 M−1 cm−1) 
were observed for both E134A-DapE and E134D-DapE. Ligand-field theory predicts that optical transitions of 
four-coordinate Co(II) complexes give rise to intense absorptions (ε>300 M−1 cm−1) in the higher-wavelength 
region (625±50 nm) owing to a comparatively small ligand-field stabilization energy, while transitions of 
octahedral Co(II) complexes have very weak absorptions (ε<30 M−1 cm−1) at lower wavelengths (525±50 nm). 
Five-coordinate Co(II) centers show intermediate features, i.e., moderate absorption intensities 
(50<ε<250 M−1 cm−1) with several maxima between 525 and 625 nm [36, 37]. On the basis of the molar 
absorptivities and d–d absorption maxima of [Co_(E134A-DapE)] and [Co_(E134D-DapE)] the first metal binding 
site is likely pentacoordinate. However, very little absorbance increase is observed upon the addition of a 
second equivalent of Co(II), similar to the situation for WT DapE [24], suggesting that the second metal binding 
site is octahedral or a very distorted pentacoordinate geometry. Because the second Co(II) ion is weakly bound 
to E134A-DapE and E134D-DapE, an equilibrium exists between free and bound Co(II); therefore, the ε value 
(approximately 10 M−1 cm−1) for the second Co(II) binding event is likely an underestimate of the actual value. 
Similar results have been reported for Co(II)-substituted AAP [26, 28, 38]. 
Taken with the optical absorption data, the EPR spectra of [Co_(E134A-DapE)] and [Co_(E134D-DapE)] are 
consistent with either a five- or a six-coordinate environment for the first Co(II) binding site. The absence of 
features due to M S =|±3/2〉 transitions render tetrahedral geometry unlikely, while the optical absorption 
coefficients would be unusually large for octahedral Co(II). The nonzero E/D value and the relatively large 
amounts of g and A strain suggest a geometry with similar electronic symmetry and orientational flexibility to 
that seen for five- or six-coordinate systems such as hexaaquo-Co(II). The lack of resolved hyperfine structure on 
the low-field line suggests coordination differences between the catalytic Co(II) ion in DapE and that in AAP. 
Interestingly, the signal is very distinct from that seen upon the addition of up to 1 equiv Co(II) to WT DapE [24]. 
The latter exhibits well-resolved resonances at g eff=5.6 and g eff=3.7, consistent with an isotropic g of 2.38 
with E/D=0.1. The WT signal is very similar to the signal from the five-coordinate Co(II) ion in the cobalt-
substituted β-lactamase, VanX [39]. Though the spin Hamiltonian parameters g (x,y) and E/D are similar for 
[Co_(DapE)] and [Co_(E134D-DapE)], the strain-dependent linewidths are clearly very different and suggest a 
level of geometric flexibility of the active-site metal ion of [Co_(E134D-DapE)] that is lacking in [Co_(DapE)]. The 
EPR data for [CoCo(E134A-DapE)] and [CoCo(E134D-DapE)] are similar to those of [CoCo(DapE)], AAP, 
and EcMetAP-I and suggest that there is little change in the electronic symmetry of the catalytic Co(II) ion upon 
binding of the second Co(II) [24, 26–28]. These data do, however, indicate substantial line-broadening of the 
low-field line of the catalytic Co(II) ion and indicate an effect either on the precise coordination geometry of this 
metal ion or on the electronic properties owing to spin–spin interactions between the two Co(II) ions. The 
spectra for [CoCo(E134A-DapE)] and [CoCo(E134D-DapE)] are consistent with five- or six-coordinate Co(II) in the 
second site with relatively high axial electronic symmetry, though the spectra are not sufficiently well resolved 
to determine the parameters precisely. The spin density appears to account for all the added Co(II) and, 
therefore, strong exchange coupling is not likely between the two cobalt ions. 
In conclusion, the data presented herein in combination with previously reported kinetic and spectroscopic 
reported for DapE establish, for the first time, that E134 is absolutely required for SDAP hydrolysis to occur. 
Since all of the active-site residues in AAP and CPG2 are strictly conserved in DapE [10] and the as-purified DapE 
enzyme exhibits approximately 90% of its activity in the presence of one Zn(II) ion, similar to AAP [40], the 
proposed catalytic mechanism for AAP was used as a starting model for DapE [35]. Once substrate binding 
occurs at the DapE active site, the substrate carbonyl group likely binds to M1 and is activated for nucleophilic 
attack (Fig. 7). Deprotonation of the metal-bound water molecule to form a nucleophilic hydroxide moiety is 
consistent with the postulated pK a of the metal-centered water molecule [10]. Once the metal-bound hydroxide 
has formed, it can attack the activated carbonyl carbon of the substrate, forming an η-1-μ-transition-state 
complex [29]. Solvent kinetic isotope effect studies yielded an inverse isotope effect that was explained by the 
attack of a Zn(II)-bound hydroxide on the amide carbonyl [10]. E134 may also provide a proton to the 
penultimate amino nitrogen, similar to that observed for AAP, returning it to its ionized state and thus 
facilitating product release. Once the products have been released, a water molecule bridging the two metal 
ions is replaced. 
 
Fig. 7 Proposed catalytic mechanism for the DapE enzyme from Haemophilus influenzae 
 
Abbreviations 
AAP: Aminopeptidase from Aeromonas proteolytica 
CPG2 : Carboxypeptidase G2 from Pseudomonas sp. strain RS-16 
DapE: dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase) 
EcMetAP-I: Methionyl aminopeptidase from Escherichia coli 
EPR: Electron paramagnetic resonance 
E134: Glutamate-134 
E151: Glutamate-151 
HEPES: 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
mDAP: meso-Diaminopimelate 
D,D-SDAP: N-Succinyl-D,D-diaminopimelate 
L,L-SDAP: N-Succinyl-L,L-diaminopimelate 
SDAP: N-Succinyl-diaminopimelic acid 
Tricine: N-Tris(hydroxymethyl)methylglycine 
Tris: Tris(hydroxymethyl)aminomethane 
WT: Wild type 
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